Bacil Pharma Ltd.
BSE: 524516 | Sector: Health care |
NSE: N.A. | ISIN Code: INE711D01018 |
BSE 00:00 | 15 Apr | 4.15 |
0 (0.00%) |
OPEN
4.15 |
HIGH
4.15 |
LOW
4.15 |
NSE 05:30 | 01 Jan | Bacil Pharma Ltd |
OPEN | 4.15 |
PREVIOUS CLOSE | 4.15 |
VOLUME | 32 |
52-Week high | 6.12 |
52-Week low | 1.57 |
P/E | |
Mkt Cap.(Rs cr) | 2 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Bacil Pharma Ltd. (BACILPHARMA) - Cash Flow
Figures in Rs crore | 2020 | 2019 | 2018 |
Opening Cash & Cash Equivalents | 0.09 | 0.27 | 0.04 |
Net Cash From Operating Activities | -0.38 | -0.30 | 1.44 |
Net Cash Used In/from Investing Activities | 0.39 | 0.28 | -1.20 |
Net Cash Used In/from Financing Activities | -0.06 | -0.16 | 0.00 |
Net (decrease)/increase In Cash and Cash Equivalents |
-0.05 | -0.18 | 0.23 |
Closing Cash & Cash Equivalents | 0.04 | 0.09 | 0.27 |
Quick Links for Bacil Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices